Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

OBJECTIVE: We investigated the feasibility of serial dynamic contrast-enhanced computed tomography (DCE-CT) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) receiving anti-angiogenic (sorafenib) and anti-EGFR (erlotinib) treatment, and correlated tumour blood flow (BF) with tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lind, Joline S. W., Meijerink, Martijn R., Dingemans, Anne-Marie C., van Kuijk, Cornelis, Öllers, Michel C., de Ruysscher, Dirk, Postmus, Pieter E., Smit, Egbert F.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978316/
https://www.ncbi.nlm.nih.gov/pubmed/20625738
http://dx.doi.org/10.1007/s00330-010-1869-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978316/
https://www.ncbi.nlm.nih.gov/pubmed/20625738
http://dx.doi.org/10.1007/s00330-010-1869-5

Ejemplares similares